{"count": 9, "results": [{"_id": "35930015", "pmid": 35930015, "title": "The Efficacy of Radiation is Enhanced by Metformin and Hyperthermia Alone or Combined Against FSaII Fibrosarcoma in C3H Mice.", "journal": "Radiat Res", "authors": ["Kim H", "Kim D", "Kim W", "Kim E", "Jang WI", "Kim MS"], "date": "2022-08-01T00:00:00Z", "doi": "10.1667/RADE-21-00231.1", "meta_date_publication": "2022 Aug 1", "meta_volume": "198", "meta_issue": "2", "meta_pages": "190-199", "score": 50267.723, "text_hl": "The Efficacy of Radiation is Enhanced by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @DISEASE_Fever @DISEASE_MESH:D005334 @@@Hyperthermia@@@ Alone or Combined Against @<m>DISEASE_Fibrosarcoma</m> @DISEASE_MESH:D005354 @@@FSaII Fibrosarcoma@@@ in C3H @SPECIES_10090 @@@Mice@@@.", "citations": {"NLM": "Kim H, Kim D, Kim W, Kim E, Jang WI, Kim MS. The Efficacy of Radiation is Enhanced by Metformin and Hyperthermia Alone or Combined Against FSaII Fibrosarcoma in C3H Mice. Radiat Res. 2022 Aug 1;198(2):190-199. PMID: 35930015", "BibTeX": "@article{35930015, title={The Efficacy of Radiation is Enhanced by Metformin and Hyperthermia Alone or Combined Against FSaII Fibrosarcoma in C3H Mice.}, author={Kim H and Kim D and Kim W and Kim E and Jang WI and Kim MS}, journal={Radiat Res}, volume={198}, number={2}, pages={190-199}}"}}, {"_id": "37738800", "pmid": 37738800, "title": "Diclofenac and metformin synergistic dose dependent inhibition of hamster fibrosarcoma, rescued with mebendazole.", "journal": "Biomed Pharmacother", "authors": ["Popović DJ", "Popović KJ", "Miljković D", "Popović JK", "Lalošević D", "Poša M", "Dolićanin Z", "Čapo I"], "date": "2023-09-20T00:00:00Z", "doi": "10.1016/j.biopha.2023.115528", "meta_date_publication": "2023 Sep 20", "meta_volume": "167", "meta_issue": "", "meta_pages": "115528", "score": 50266.164, "text_hl": "@CHEMICAL_Diclofenac @CHEMICAL_MESH:D004008 @@@Diclofenac@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ synergistic dose dependent inhibition of hamster @<m>DISEASE_Fibrosarcoma</m> @DISEASE_MESH:D005354 @@@fibrosarcoma@@@, rescued with @CHEMICAL_Mebendazole @CHEMICAL_MESH:D008463 @@@mebendazole@@@.", "citations": {"NLM": "Popović DJ, Popović KJ, Miljković D, Popović JK, Lalošević D, Poša M, Dolićanin Z, Čapo I. Diclofenac and metformin synergistic dose dependent inhibition of hamster fibrosarcoma, rescued with mebendazole. Biomed Pharmacother. 2023 Sep 20;167():115528. PMID: 37738800", "BibTeX": "@article{37738800, title={Diclofenac and metformin synergistic dose dependent inhibition of hamster fibrosarcoma, rescued with mebendazole.}, author={Popović DJ and Popović KJ and Miljković D and Popović JK and Lalošević D and Poša M and Dolićanin Z and Čapo I}, journal={Biomed Pharmacother}, volume={167}, pages={115528}}"}}, {"_id": "32707437", "pmid": 32707437, "title": "Co-treatment with nitroglycerin and metformin exhibits physicochemically and pathohistologically detectable anticancer effects on fibrosarcoma in hamsters.", "journal": "Biomed Pharmacother", "authors": ["Popović KJ", "Popović DJ", "Miljković D", "Popović JK", "Lalošević D", "Čapo I"], "date": "2020-10-01T00:00:00Z", "doi": "10.1016/j.biopha.2020.110510", "meta_date_publication": "2020 Oct", "meta_volume": "130", "meta_issue": "", "meta_pages": "110510", "score": 50264.527, "text_hl": "We investigated the effect of @CHEMICAL_Nitroglycerin @CHEMICAL_MESH:D005996 @@@nitroglycerin@@@ with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Fibrosarcoma</m> @DISEASE_MESH:D005354 @@@fibrosarcoma@@@ in @SPECIES_10026 @@@hamsters@@@. ", "citations": {"NLM": "Popović KJ, Popović DJ, Miljković D, Popović JK, Lalošević D, Čapo I. Co-treatment with nitroglycerin and metformin exhibits physicochemically and pathohistologically detectable anticancer effects on fibrosarcoma in hamsters. Biomed Pharmacother. 2020 Oct;130():110510. PMID: 32707437", "BibTeX": "@article{32707437, title={Co-treatment with nitroglycerin and metformin exhibits physicochemically and pathohistologically detectable anticancer effects on fibrosarcoma in hamsters.}, author={Popović KJ and Popović DJ and Miljković D and Popović JK and Lalošević D and Čapo I}, journal={Biomed Pharmacother}, volume={130}, pages={110510}}"}}, {"_id": "34536762", "pmid": 34536762, "title": "Disulfiram and metformin combination anticancer effect reversible partly by antioxidant nitroglycerin and completely by NF-kappaB activator mebendazole in hamster fibrosarcoma.", "journal": "Biomed Pharmacother", "authors": ["Popović KJ", "Popović DJ", "Miljković D", "Popović JK", "Lalošević D", "Poša M", "Čapo I"], "date": "2021-11-01T00:00:00Z", "doi": "10.1016/j.biopha.2021.112168", "meta_date_publication": "2021 Nov", "meta_volume": "143", "meta_issue": "", "meta_pages": "112168", "score": 50256.08, "text_hl": "We investigated the anticancer effect of @CHEMICAL_Disulfiram @CHEMICAL_MESH:D004221 @@@disulfiram@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ combination on @<m>DISEASE_Fibrosarcoma</m> @DISEASE_MESH:D005354 @@@fibrosarcoma@@@ in @SPECIES_10026 @@@hamsters@@@. ", "citations": {"NLM": "Popović KJ, Popović DJ, Miljković D, Popović JK, Lalošević D, Poša M, Čapo I. Disulfiram and metformin combination anticancer effect reversible partly by antioxidant nitroglycerin and completely by NF-kappaB activator mebendazole in hamster fibrosarcoma. Biomed Pharmacother. 2021 Nov;143():112168. PMID: 34536762", "BibTeX": "@article{34536762, title={Disulfiram and metformin combination anticancer effect reversible partly by antioxidant nitroglycerin and completely by NF-kappaB activator mebendazole in hamster fibrosarcoma.}, author={Popović KJ and Popović DJ and Miljković D and Popović JK and Lalošević D and Poša M and Čapo I}, journal={Biomed Pharmacother}, volume={143}, pages={112168}}"}}, {"_id": "29243803", "pmid": 29243803, "title": "Effect of metformin on fibrosarcoma in hamsters.", "journal": "Eur Rev Med Pharmacol Sci", "authors": ["Popović DJ", "Lalošević D", "Miljković D", "Popović KJ", "Čapo I", "Popović JK"], "date": "2017-12-01T00:00:00Z", "doi": "10.26355/eurrev_201712_13941", "meta_date_publication": "2017 Dec", "meta_volume": "21", "meta_issue": "23", "meta_pages": "5499-5505", "score": 50086.984, "text_hl": "Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Fibrosarcoma</m> @DISEASE_MESH:D005354 @@@fibrosarcoma@@@ in @SPECIES_10026 @@@hamsters@@@.", "citations": {"NLM": "Popović DJ, Lalošević D, Miljković D, Popović KJ, Čapo I, Popović JK. Effect of metformin on fibrosarcoma in hamsters. Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5499-5505. PMID: 29243803", "BibTeX": "@article{29243803, title={Effect of metformin on fibrosarcoma in hamsters.}, author={Popović DJ and Lalošević D and Miljković D and Popović KJ and Čapo I and Popović JK}, journal={Eur Rev Med Pharmacol Sci}, volume={21}, number={23}, pages={5499-5505}}"}}, {"_id": "29762853", "pmid": 29762853, "title": "Caffeine induces metformin anticancer effect on fibrosarcoma in hamsters.", "journal": "Eur Rev Med Pharmacol Sci", "authors": ["Popović DJ", "Lalošević D", "Miljković D", "Popović KJ", "Čapo I", "Popović JK"], "date": "2018-04-01T00:00:00Z", "doi": "10.26355/eurrev_201804_14840", "meta_date_publication": "2018 Apr", "meta_volume": "22", "meta_issue": "8", "meta_pages": "2461-2467", "score": 50073.72, "text_hl": "@CHEMICAL_Caffeine @CHEMICAL_MESH:D002110 @@@Caffeine@@@ induces @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ anticancer effect on @<m>DISEASE_Fibrosarcoma</m> @DISEASE_MESH:D005354 @@@fibrosarcoma@@@ in @SPECIES_10026 @@@hamsters@@@.", "citations": {"NLM": "Popović DJ, Lalošević D, Miljković D, Popović KJ, Čapo I, Popović JK. Caffeine induces metformin anticancer effect on fibrosarcoma in hamsters. Eur Rev Med Pharmacol Sci. 2018 Apr;22(8):2461-2467. PMID: 29762853", "BibTeX": "@article{29762853, title={Caffeine induces metformin anticancer effect on fibrosarcoma in hamsters.}, author={Popović DJ and Lalošević D and Miljković D and Popović KJ and Čapo I and Popović JK}, journal={Eur Rev Med Pharmacol Sci}, volume={22}, number={8}, pages={2461-2467}}"}}, {"_id": "31423237", "pmid": 31423237, "pmcid": "PMC6614679", "title": "Physicochemical and pathohistological changes in experimental fibrosarcoma tumors of hamsters treated with metformin and itraconazole", "journal": "Oncol Lett", "authors": ["Popović KJ", "Popović DJ", "Miljković D", "Lalošević D", "Čapo I", "Popović JK"], "date": "2019-08-01T00:00:00Z", "doi": "10.3892/ol.2019.10509", "meta_date_publication": "2019 Aug", "meta_volume": "18", "meta_issue": "2", "meta_pages": "1697-1712", "score": 50070.184, "text_hl": "Therefore, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may have the potential to prevent @<m>DISEASE_Fibrosarcoma</m> @DISEASE_MESH:D005354 @@@fibrosarcoma metastasis@@@. ", "citations": {"NLM": "Popović KJ, Popović DJ, Miljković D, Lalošević D, Čapo I, Popović JK. Physicochemical and pathohistological changes in experimental fibrosarcoma tumors of hamsters treated with metformin and itraconazole Oncol Lett. 2019 Aug;18(2):1697-1712. PMID: 31423237", "BibTeX": "@article{31423237, title={Physicochemical and pathohistological changes in experimental fibrosarcoma tumors of hamsters treated with metformin and itraconazole}, author={Popović KJ and Popović DJ and Miljković D and Lalošević D and Čapo I and Popović JK}, journal={Oncol Lett}, volume={18}, number={2}, pages={1697-1712}}"}}, {"_id": "20590612", "pmid": 20590612, "title": "Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase Calpha-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activator protein-1.", "journal": "Br J Pharmacol", "authors": ["Hwang YP", "Jeong HG"], "date": "2010-07-01T00:00:00Z", "doi": "10.1111/j.1476-5381.2010.00762.x", "meta_date_publication": "2010 Jul", "meta_volume": "160", "meta_issue": "5", "meta_pages": "1195-211", "score": 50054.695, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ therefore has the potential to be a potent anti-@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ drug in therapeutic strategies for @<m>DISEASE_Fibrosarcoma</m> @DISEASE_MESH:D005354 @@@fibrosarcoma metastasis@@@.", "citations": {"NLM": "Hwang YP, Jeong HG. Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase Calpha-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activator protein-1. Br J Pharmacol. 2010 Jul;160(5):1195-211. PMID: 20590612", "BibTeX": "@article{20590612, title={Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase Calpha-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activator protein-1.}, author={Hwang YP and Jeong HG}, journal={Br J Pharmacol}, volume={160}, number={5}, pages={1195-211}}"}}, {"_id": "30508092", "pmid": 30508092, "pmcid": "PMC6440441", "title": "Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects", "journal": "Int Immunol", "authors": ["Uehara T", "Eikawa S", "Nishida M", "Kunisada Y", "Yoshida A", "Fujiwara T", "Kunisada T", "Ozaki T", "Udono H"], "date": "2019-03-28T00:00:00Z", "doi": "10.1093/intimm/dxy079", "meta_date_publication": "2019 Mar 28", "meta_volume": "31", "meta_issue": "4", "meta_pages": "187-198", "score": 50041.12, "text_hl": "Regulation of these cell types is a primary goal for achieving efficient @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ immunotherapy. We found that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@GENE_SLTM @GENE_79811 @@@Met@@@) induces @GENE_ITGAM @GENE_16409 @@@CD11b@@@+-cell-mediated growth inhibition of a @CELLLINE_CVCL:V454 @@@K7M2neo@@@ @DISEASE_Osteosarcoma @DISEASE_MESH:D012516 @@@osteosarcoma@@@ independent of T cells, as growth inhibition of @CELLLINE_CVCL:V454 @@@K7M2neo@@@ was still observed in wild-type (WT) @SPECIES_10090 @@@mice@@@ depleted of T cells by antibodies and in @DISEASE_X_Linked_Combined_Immunodeficiency_Diseases @DISEASE_MESH:D053632 @@@SCID@@@; this contrasted with the effect of @GENE_SLTM @GENE_79811 @@@Met@@@ on @CELLLINE_CVCL:5798 @@@Meth A@@@ @<m>DISEASE_Fibrosarcoma</m> @DISEASE_MESH:D005354 @@@fibrosarcoma@@@, which was entirely T-cell-dependent. ", "citations": {"NLM": "Uehara T, Eikawa S, Nishida M, Kunisada Y, Yoshida A, Fujiwara T, Kunisada T, Ozaki T, Udono H. Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects Int Immunol. 2019 Mar 28;31(4):187-198. PMID: 30508092", "BibTeX": "@article{30508092, title={Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects}, author={Uehara T and Eikawa S and Nishida M and Kunisada Y and Yoshida A and Fujiwara T and Kunisada T and Ozaki T and Udono H}, journal={Int Immunol}, volume={31}, number={4}, pages={187-198}}"}}]}